Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene
Jonathan Y. Bass, Justin A. Caravella, Lihong Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2010
Cited by 60 works. doi:10.1016/j.bmcl.2010.12.089
Authors
- Jonathan Y. Bass
- Justin A. Caravella
- Lihong Chen
- Katrina L. Creech
- David N. Deaton
- Kevin P. Madauss
- Harry B. Marr
- Robert B. McFadyen
- Aaron B. Miller
- Wendy Y. Mills
- Frank Navas
- Derek J. Parks
- Terrence L. Jr. Smalley
- Paul K. Spearing
- Dan Todd
- Shawn P. Williams
- G. Bruce Wisely
References
- Identification of a nuclear receptor that is activated by farnesol metabolites
- Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
- A G Protein-coupled Receptor Responsive to Bile Acids
- Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening
- Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR
- Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
- Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
- Farnesoid X receptor is essential for normal glucose homeostasis